Latest News and Press Releases
Want to stay updated on the latest news?
-
Austin, TX, USA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “AI in Synthetic Biology Market Size, Trends and Insights By Technology (Gene...
-
Austin, TX, USA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Veterinary Regenerative Medicine Market Size, Trends and Insights By Product...
-
Austin, TX, USA, July 25, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “CRISPR Gene Editing Market Size, Trends and Insights By Product (Kits and...
-
Austin, TX, USA, June 25, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cell and Gene Therapy Market Size, Trends and Insights By Therapy Type (Cell...
-
Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration
-
Austin, TX, USA, April 30, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Multi Cancer Early Detection Market Size, Trends and Insights By Type (Liquid...
-
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
-
Genetic Technologies Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
-
MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power...
-
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year